Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Neurogenetics
- Overview
- Historical approaches
- Linkage mapping
- LRRK2 as an example
- Typical pedigree
- Candidate gene association studies
- Problems with these approaches
- Advances in technology
- Whole-genome genotyping - overview
- Whole-genome genotyping
- Example of whole-genome genotyping
- Genome-wide association studies
- Example of genome-wide association study
- GWAS - success vs. caveats
- Autozygosity mapping (1)
- Family studies using whole-genome genotyping
- Autozygosity mapping (2)
- Custom genotyping arrays
- Summary: whole-genome genotyping
- Next-generation sequencing
- Cost per genome
- Sequencing-by-synthesis
- Whole-genome vs. whole-exome sequencing
- Whole-exome sequencing
- Challenges: whole-exome sequencing (1)
- Challenges: whole-exome sequencing (2)
- Example of whole-exome sequencing
- Whole-exome association studies
- Unbiased methods has led to unexpected results
- Summary: “next-generation” sequencing
- Genetic architecture of disease
- Tackling genetic architecture of disease
- Genetic architecture of Parkinson’s disease
- Cost of genetic studies - 2014
- Conclusions
Topics Covered
- Historical approaches to genetic studies
- Genome-Wide Genotyping
- Genome-Wide Association Studies
- Next-Generation Sequencing
- How we use novel technologies to understand the genetic architecture of disease
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Bras, J.M. (2014, July 1). Genetic methods in the study of neurological diseases: the genetic basis of neurological disorders [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/FWGH2417.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Jose Miguel Bras has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Genetic methods in the study of neurological diseases: the genetic basis of neurological disorders
Published on July 1, 2014
38 min
A selection of talks on Neuroscience
Transcript
Please wait while the transcript is being prepared...
0:00
My name is Jose Bras.
I am a researcher at the Institute
of Neurology at UCL in London.
And in this lecture, I'm going
to try and talk a little bit
about the genetic methods
that we're currently
using in the study of
neurological diseases.
0:15
So in neurogenetics,
we currently have
two main aims in the
study of disease.
The first one, I'd say, is when we
want to identify the genetic cause
of a condition when a condition is
seen as segregating in a family,
for example, and we don't know
which gene is causing the disorder.
So that's one of the
main goals that we have.
The second one is perhaps finding
genetic variants that modulate
the risk of an
individual by increasing
it or decreasing it to
develop a condition,
and also best genetic
variants that modulate
the progression of a disease.
And both these things
are incredibly important
and have widespread implications,
not just for the patients
themselves, but particularly because
they help us understand how and why
the disease starts and
how and why it progresses.
1:08
So in this lecture I'm going to
try and touch on three points.
I'm going to talk a little bit
about historical approaches
to understanding
genetics of disease.
I'm going to then go on to talk a
little bit about recent advances
in technology that have
really enabled us to do things
that weren't possible
a few years ago.
And as I go along, I'll try and talk
about how these technologies have
really allowed us to better
understand neurological disorders.
1:35
So on historical
approaches, there are many.
I'm going to focus on the two which
are probably the most known ones.
I'm going to just briefly go over
them, see how they were applied
to the understanding of disease,
and perhaps give a few examples
of success cases that we
had with those approaches.
The first one I'm going to
talk about is linkage mapping.
And this was widely used to
identify disease-causing genes,
namely when we had a disease
segregating in a family.
And the second approach
that I'm going to talk about
is candidate gene
association studies.
Here, the aim wasn't usually to
identify disease-causing genes,
but instead to identify
genes that were involved
in a disease, and not
necessarily causing it.
Hide